Biodesix, Inc.

NASDAQ:BDSX

0.7221 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -42.931-52.146-65.447-43.159-31.35-30.726-26.166
Depreciation & Amortization 5.4565.5075.8443.1782.9032.7931.74
Deferred Income Tax 000-2.1051.5962.3630.047
Stock Based Compensation 6.6385.3735.9614.9443.7090.170.142
Change In Working Capital -21.66911.304-4.3444.591-4.801-1.6450.253
Accounts Receivables -1.811-4.718-1.50111.454-10.308-3.646-0.146
Inventory 0.0220.1660.9067.425-11.6540.017-0.389
Accounts Payables 1.6370.513-0.773-7.42511.6541.1930.342
Other Working Capital -21.51715.343-2.976-6.8635.5070.7910.446
Other Non Cash Items 3.8577.09213.0144.3286.5775.3196.307
Operating Cash Flow -48.649-22.87-44.972-28.223-21.366-21.726-17.677
Investing Activities:
Investments In Property Plant And Equipment -3.23-22.919-3.534-2.547-2.177-1.416-0.617
Acquisitions Net 0000-0.75-0.4560
Purchases Of Investments 0000000
Sales Maturities Of Investments 0000000
Other Investing Activites -0.21-0.143-0.236-0.306-0.232-0.106-0.119
Investing Cash Flow -3.44-23.062-3.534-2.547-2.927-1.872-0.617
Financing Activities:
Debt Repayment -0.0519.95116.498-15.3516.0413.044-12.646
Common Stock Issued 55.62528.12659.53816.3437210.04731.55
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities -3.524-8.948-17.1540.269-6.90919.92831.678
Financing Cash Flow 52.0529.12958.8821.26281.13122.97219.032
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -0.039-16.80310.376-29.50856.838-0.6260.738
Cash At End Of Period 26.33226.37143.17432.79862.3065.4686.094